SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
Endocrine-Related Cancer · 2023
DOI: 10.1530/erc-22-0198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Francesca Branzoli und 15 weiteren Autor:innen. Beteiligte Einrichtung: Paris Brain Institute - Institut du Cerveau (ICM), Center for Neuroimaging Research (CENIR), Paris, France. Hauptthemen laut MEDLINE: Paraganglioma, Pituitary Neoplasms, Pheochromocytoma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Germline mutations in genes encoding succinate dehydrogenase (SDH) are frequently involved in pheochromocytoma/paraganglioma (PPGL) development and were implicated in patients with the ‘3PAs’ syndrome (associating pituitary adenoma (PA) and PPGL) or isolated PA. However, the causality link between SDHx mutation and PA remains difficult to establish, and in vivo tools for detecting hallmarks of SDH deficiency are scarce. Proton magnetic resonance spectroscopy ( 1 H-MRS) can detect succinate in vivo as a biomarker of SDHx mutations in PGL. The objective of this study was to demonstrate the causality link between PA and SDH deficiency in vivo using 1 H-MRS as a novel noninvasive tool for succinate detection in PA. Three SDHx -mutated patients suffering from a PPGL and a macroprolactinoma and one patient with an apparently sporadic non-functioning pituitary macroadenoma underwent MRI examination at 3 T. An optimized 1 H-MRS semi-LASER sequence (TR = 2500 ms, TE = 144 ms) was employed for the detection of succinate in vivo. Succinate and choline-containing compounds were identified in the MR spectra as single resonances at 2.44 and 3.2 ppm, respectively. Choline compounds were detected in all the tumors (three PGL and four PAs), while a succinate peak was only observed in the three macroprolactinomas and the three PGL of SDHx -mutated patients, demonstrating SDH deficiency in these tumors. In conclusion, the detection of succinate by 1 H-MRS as a hallmark of SDH deficiency in vivo is feasible in PA, laying the groundwork for a better understanding of the biological link between SDHx mutations and the development of these tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paris Brain Institute - Institut du Cerveau (ICM), Center for Neuroimaging Research (CENIR), Paris, France.
- Sorbonne University, UMR S 1127, Inserm U 1127, CNRS UMR 7225, ICM, Paris, France.
- Sorbonne University, nuclear medicine department, Pitié-Salpêtrière Hospital, Assistance -Publique Hôpitaux de Paris, Paris, France.
- Paris Cardiovascular Research Center (PARCC), Inserm, Paris, France.
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA.
- Endocrinology department, Lariboisière Hospital, Assistance -Publique Hôpitaux de Paris, Paris, France.
ORCID-Profile: Betty Salgues, Małgorzata Marjańska, Julien Riancho, Judith Favier, Charlotte Lussey-Lepoutre
Förderung
- NINDS NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Branzoli, F., Salgues, B., Marjańska, M., Laloi-Michelin, M., Herman, P., Le Collen, L., Delemer, B., Riancho, J., Kuhn, E., Jublanc, C., Burnichon, N., Amar, L., Favier, J., Gimenez-Roqueplo, A. P., Buffet, A., & Lussey-Lepoutre, C. (2023). SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?. Endocrine-Related Cancer. https://doi.org/10.1530/erc-22-0198
Vancouver
Branzoli F, Salgues B, Marjańska M, Laloi-Michelin M, Herman P, Le Collen L, et al. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?. Endocrine-Related Cancer. 2023. doi:10.1530/erc-22-0198
BibTeX
@article{Branzoli2023,
author = {Branzoli, Francesca and Salgues, Betty and Marjańska, Małgorzata and Laloi-Michelin, Marie and Herman, Philippe and Le Collen, Lauriane and Delemer, Brigitte and Riancho, Julien and Kuhn, Emmanuelle and Jublanc, Christel and Burnichon, Nelly and Amar, Laurence and Favier, Judith and Gimenez-Roqueplo, Anne-Paule and Buffet, Alexandre and Lussey-Lepoutre, Charlotte},
title = {SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?},
journal = {Endocrine-Related Cancer},
year = {2023},
doi = {10.1530/erc-22-0198}
}
EUVIMED